Show
10
20
30
40
results per page
Characterization of interferon-lambda 1 as a treatment for COVID-19
Tyrrell, D. Lorne J |
University of Alberta | Operating Grant | $499,775
CIHR Alberta 2020
Read More
Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase
James, Michael N |
University of Alberta | Operating Grant | $311,000
CIHR Alberta 2020
Read More
Development and Evaluation of SARS-CoV-2 RNA Polymerase Inhibitors
Götte, Matthias |
University of Alberta | Operating Grant | $675,000
CIHR Alberta 2020
Read More
Mobilizing Knowledge on the Use of Virtual Care Interventions to Provide Trauma-Focused Treatment to Individuals and Families At-Risk of Domestic Violence During COVID-19
Montesanti, Stephanie R |
University of Alberta | Operating Grant | $50,000
CIHR Alberta 2020
Read More
Determinants of Community COVID Transmission: Learning from the Hutterites
Loeb, Mark B |
McMaster University | Operating Grant | $1,482,473
CIHR Ontario 2020
Read More
Neutralizing Antibodies as SARS-CoV-2 Therapeutics
Rini, James M |
University of Toronto | Operating Grant | $535,318
CIHR Ontario 2020
Read More
Development of field-deployable and point-of-need diagnostics for SARS-CoV-2 using CRISPR-based technology
Pickering, Bradley |
Canadian Science Centre for Human and Animal Health | Operating Grant | $411,820
CIHR Manitoba 2020
Read More
Development of a yeast-based immunoassay for SARS-CoV-2 serologic testing amenable to inexpensive local production
Mcmillen, David R |
University of Toronto | Operating Grant | $179,140
CIHR Ontario 2020
Read More
Can COVID‑19 and maternal antibodies to SARS-CoV-2 be transmitted through human milk? Implications for breastfeeding and human milk banking
O'Connor, Deborah L |
Sinai Health System | Operating Grant | $182,538
CIHR Ontario 2020
Read More
Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection
Babu, Mohan |
The University of Regina | Operating Grant | $937,950
CIHR Saskatchewan 2020
Read More